Global Lungs in Vitro Market to reach USD 707.5 million by 2026

Global Lungs in Vitro Market Size by Type (2D Cell Models, 3D Cell Models) and Regional Forecasts 2019-2026
Product Code:  HALDAT_67847732
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Lungs in Vitro Market, by Type, 2016-2026 (USD Billion)
1.3.2.	Lungs in Vitro Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Lungs in Vitro Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Lungs in Vitro Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Lungs in Vitro Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Lungs in Vitro Market, by Type 
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Lungs in Vitro Market, Sub Segment Analysis
5.3.1.	  2D Cell Models     
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	   3D Cell Models
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Lungs in Vitro Market, by Regional Analysis
6.1.	Lungs in Vitro Market, Regional Market Snapshot (2016-2026)
6.2.	North America Lungs in Vitro Market Snapshot
6.2.1.	U.S.
6.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.2.1.2.	 Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.2.2.	 Canada
6.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.2.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.	 Europe Lungs in Vitro Market Snapshot
6.3.1.	U.K. 
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.2.	 Rest of Europe
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.	 Asia Lungs in Vitro Market Snapshot
6.4.1.	China 
6.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.2.	 India 
6.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.3.	 Japan
6.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.4.4.	 Rest of Asia Pacific
6.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.5.	 Latin America Lungs in Vitro Market Snapshot
6.5.1.	Brazil 
6.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.5.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.5.2.	 Mexico 
6.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.5.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.6.	Rest of The World 
6.6.1.	Middle East and Africa
6.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.6.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
Chapter 7.	Competitive Intelligence
7.1.	Company Market Share (Subject to Data Availability)
7.2.	Top Market Strategies
7.3.	Company Profiles
7.3.1.	  ATCC
7.3.1.1.	Overview
7.3.1.2.	Financial (Subject to Data Availability)
7.3.1.3.	Product Summary
7.3.1.4.	Recent Developments
7.3.2.	   Lonza
7.3.3.	 Epithelix
7.3.4.	 Mattek
7.3.5.	 Emulate
7.3.6.	 Tissuse
7.3.7.	 Mimetas
7.3.8.	 Insphero
7.3.9.	 Cn Bio Innovations 
7.3.10.	AlveoliX
Chapter 8.	Research Process
8.1.	Research Process
8.1.1.	Data Mining
8.1.2.	Analysis
8.1.3.	Market Estimation
8.1.4.	Validation
8.1.5.	Publishing
8.1.6.	Research Assumption

Global Lungs in Vitro Market valued approximately USD 192.1 million in 2018 is anticipated to grow with a healthy growth rate of more than 17.7% over the forecast period 2019-2026. Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology, and the development of new 3D in vitro models are factors driving the growth of this market. Further, increasing number of drug discovery activities coupled with growing application of lungs in vitro in regenerative medicines, tissue engineering and oncology research is expected to create lucrative growth opportunity in the market over the forecast period. However, lack of skilled professionals is expected to hamper the market growth over the forecast period.
The regional analysis of global Lungs in Vitro market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing funding and research and development activities in the region by the biotechnology companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising disposable income, rising government initiatives and improving healthcare infrastructure would create lucrative growth prospects for the Lungs in Vitro market across Asia-Pacific region.

Major market player included in this report are:
ATCC, Lonza
Epithelix
Mattek, Emulate
Tissuse, Mimetas
Insphero
Cn Bio Innovations

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
2D Cell Models
3D Cell Models
Commercial 3D Cell Models
Inhouse 3D Cell Models
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Lungs in Vitro in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…